APGE
HEALTHCAREApogee Therapeutics, Inc. Common Stock
AI Insight
What's Moving APGE Today?
No stock-specific AI insight has been generated for APGE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$34.34$133.00
$132.86
Fundamentals
Market Cap$6.8B
P/E Ratio—
EPS$-4.33
Dividend Yield—
Dividend / Share—
ROE-28.5%
Profit Margin—
Debt / Equity—
Trading
Volume7.5M
Avg Volume (10D)—
Shares Outstanding61.9M
APGE News
28 articles- Company News for Jun 23, 2026Yahoo Finance·Jun 23, 2026
- 3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal247 Wall St·Jun 23, 2026
- Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee AcquisitionYahoo Finance·Jun 23, 2026
- Why AbbVie Stock Jumped TodayMotley Fool·Jun 23, 2026
- Why Did INTC, KEEL, APGE Stocks Hit 52-Week Highs Today?Stocktwits·Jun 23, 2026
- Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B MergerYahoo Finance·Jun 23, 2026
- AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King?The Motley Fool·Jun 22, 2026
- Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout OfferMotley Fool·Jun 22, 2026
- The $11 Billion Reason Abbvie Stock Is Up TodayBarchart·Jun 22, 2026
- AbbVie Goes On The Offensive With $10.9 Billion TakeoverYahoo Finance·Jun 22, 2026
- Update: US Equity Indexes Mixed as Communication Services Sector Slides, Treasury Yields SurgeYahoo Finance·Jun 22, 2026
- Sector Update: Healthcare Stocks Rise Late AfternoonYahoo Finance·Jun 22, 2026
- Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics—and Why the Stock Is RisingYahoo Finance·Jun 22, 2026
- AbbVie's $10.9 Billion Apogee Deal Joins a $200 Billion Pharma SpreeYahoo Finance·Jun 22, 2026
- Update: Equities Mixed Intraday, Oil Falls as US-Iran Talks AdvanceYahoo Finance·Jun 22, 2026
- Top Midday GainersYahoo Finance·Jun 22, 2026
- Update: US Equity Indexes Mixed Amid Steep Decline in Communication Services, Surging Treasury YieldsYahoo Finance·Jun 22, 2026
- AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 BillionYahoo Finance·Jun 22, 2026
- Top Midday Stories: Treasury Authorizes Sale of Iranian Oil; SpaceX launches First Inaugural Bond IssuanceYahoo Finance·Jun 22, 2026
- AbbVie deepens immunology legacy in $10.9bn Apogee buyoutPharmaceutical-technology·Jun 22, 2026
- Apogee Therapeutics Inc (APGE) Dividends & Stock Splits: Historical Payouts and Event TimelineTradingKey·Jun 18, 2026
- Apogee Therapeutics (APGE) director receives stock options for 7,657 sharesStock Titan·Jun 12, 2026
- Apogee Therapeutics (APGE) links 7,657-share option grant to directorStock Titan·Jun 12, 2026
- Venrock-linked director at Apogee (APGE) awarded 7,657 stock optionsStock Titan·Jun 12, 2026
- Apogee falls following phase 2 results for zumilokibart in atopic dermatitisSeeking Alpha·May 27, 2026
- Apogee Therapeutics (APGE) CEO sells 20,000 shares under 10b5-1 planStock Titan·May 16, 2026
- Apogee CEO Sells 20,000 Shares as Stock Surges Nearly 100% in a Year, but Here's What Really Matters for InvestorsThe Motley Fool·Mar 26, 2026
- Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public OfferingGlobeNewswire Inc.·Mar 25, 2026
All 28 articles loaded
Price Data
Open$132.62
Previous Close$132.55
Day High$132.95
Day Low$132.54
52 Week High$133.00
52 Week Low$34.34
52-Week Range
$34.34$133.00
$132.86
Fundamentals
Market Cap$6.8B
P/E Ratio—
EPS$-4.33
Dividend Yield—
Dividend / Share—
ROE-28.5%
Profit Margin—
Debt / Equity—
Trading
Volume7.5M
Avg Volume (10D)—
Shares Outstanding61.9M
About Apogee Therapeutics, Inc. Common Stock
Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company is headquartered in Waltham, Massachusetts.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—